Baylor College of Medicine: Key Ethics and Policy Issues in the Clinical Use of Psychedelic Therapies
June 05, 2024
June 05, 2024
HOUSTON, Texas, June 5 (TNSres) -- The Baylor College of Medicine issued the following news:
As government agencies around the globe contemplate approval of the first psychedelic medicines, many questions remain about their ethical integration into mainstream medical practice. In a new paper published in JAMA Network Open, a team of bioethicists, clinicians, researchers, Indigenous groups, industry, philanthropy, veterans, retreat facilitators and training program leaders identify k . . .
As government agencies around the globe contemplate approval of the first psychedelic medicines, many questions remain about their ethical integration into mainstream medical practice. In a new paper published in JAMA Network Open, a team of bioethicists, clinicians, researchers, Indigenous groups, industry, philanthropy, veterans, retreat facilitators and training program leaders identify k . . .